Trial site
Osteo Medic s.c. Artur Racewicz Jerzy Supronik
- 13running trials
- 10closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Psoriasis11 trials
- Psoriatic arthritis9 trials
- Ankylosing spondylitis2 trials
- Type 2 diabetes2 trials
- Alopecia areata1 trial
- Chronic kidney disease1 trial
- Diabetic neuropathy1 trial
- Obesity1 trial
- Osteoporosis1 trial
- Rheumatoid arthritis1 trial
- Vitiligo1 trial
- Phase
- Phase 320 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting13 trials
- Completed10 trials
- Suspended1 trial
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- AbbVie4 trials
- Bristol-Myers Squibb2 trials
- Janssen - Cilag International2 trials
- Novo Nordisk A/S2 trials
- and 9 more
Running trials
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Active, not recruiting
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Completed
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
Completed
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
Completed
A study to test if izokibep improves psoriatic arthritis symptoms and to see how safe izokibep is
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Completed
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026